Xtx Topco LTD An2 Therapeutics, Inc. Transaction History

Xtx Topco LTD

$1.3 Billion
Q3 2024

A detailed history of Xtx Topco LTD transactions in An2 Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 23,659 shares of ANTX stock, worth $25,315. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,659

Holding current value

$25,315

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 14, 2024	BUY	$0.98 - $2.96 $23,185 - $70,030	23,659 New	23,659 $25,000
Q1 2024 May 13, 2024	BUY	$2.78 - $21.53 $107,491 - $832,478	38,666 New	38,666 $125,000

Others Institutions Holding ANTX

# of Institutions

Shares Held

13.5M

Call Options Held

Put Options Held

Bml Capital Management, LLC Zionsville, IN

5.75M
Shares

$6.15 Million
3.62% of portfolio
Ra Capital Management, L.P. Boston, MA

2M
Shares

$2.14 Million
0.03% of portfolio
Tcg Crossover Management, LLC Palo Alto, CA

1.56M
Shares

$1.66 Million
0.22% of portfolio
Vanguard Group Inc Valley Forge, PA

1.04M
Shares

$1.11 Million
0.0% of portfolio
Acuitas Investments, LLC

446K
Shares

$476,987
0.23% of portfolio

View Full List

About AN2 Therapeutics, Inc.

Ticker ANTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,402,700
Market Cap $20.8M
Description
AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for rare, chronic, and serious infectious diseases. It is developing epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial lung disease. The company was incorporated in 2017 and is headquartered in Menl...

More about ANTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account